A new analysis of the thriving synthetic biology patent landscape has revealed the top patent owners and dealmakers in this space, as well as those appearing most often in the courtroom. Among its key findings are that Hewlett Packard (HP) has expanded into the life sciences arena and that the microfluidics market is booming. What’s more, a look at patenting activity by jurisdiction shows a stark contrast between the behaviours of US and Chinese players – and plenty of opportunities for collaboration between the two.

Want to read more?

Register to access two of our subscriber-only articles per month

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts

Already registered? Log in

What our customers are saying

Straight talk on key IP issues, IAM aims to provide executive managers with the business perspective that often gets lost in technical jargon and legal details.

Gene Potkay
Senior vice president of intellectual property
The Nielsen Company

Benefits

Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.

Why subscribe?